ym 529 has been researched along with cholecalciferol in 1 studies
Studies (ym 529) | Trials (ym 529) | Recent Studies (post-2010) (ym 529) | Studies (cholecalciferol) | Trials (cholecalciferol) | Recent Studies (post-2010) (cholecalciferol) |
---|---|---|---|---|---|
140 | 23 | 71 | 8,234 | 1,425 | 3,471 |
Protein | Taxonomy | ym 529 (IC50) | cholecalciferol (IC50) |
---|---|---|---|
Vitamin D3 receptor | Homo sapiens (human) | 0.087 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukunaga, M; Hagino, H; Matsumoto, T; Nakamura, T; Nakano, T; Ohashi, Y; Shiraki, M; Takaoka, K | 1 |
1 trial(s) available for ym 529 and cholecalciferol
Article | Year |
---|---|
Three years of treatment with minodronate in patients with postmenopausal osteoporosis.
Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Bone Resorption; Calcium, Dietary; Cholecalciferol; Cohort Studies; Combined Modality Therapy; Dietary Supplements; Diphosphonates; Double-Blind Method; Female; Humans; Imidazoles; Incidence; Lumbar Vertebrae; Middle Aged; Osteogenesis; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Time Factors | 2012 |